Does the Volume of Medication Affect the Success of Labor Epidural Analgesia

NCT07684365 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2026-07-06

No results posted yet for this study

Summary

The purpose of this study is to evaluate whether changing the volume and concentration of a medication affects the quality of pain relief and the side effects associated with labor epidural analgesia.

Conditions

  • Labor Pain and to Reduce Pain

Interventions

DRUG

administration of bupivacaine 7.5 mg and fentanyl 24 mcg every 40 minutes

Dose of medication delivered using a programmed intermittent epidural bolus

Sponsors & Collaborators

Principal Investigators

  • Philip Hess, MD · Beth Israel Deaconess Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-15
Primary Completion
2027-12-31
Completion
2027-12-31
FDA Drug
Yes

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07684365 on ClinicalTrials.gov